"We are delighted about the great interest in the Life Science Investors' Day. This shows us as BioLabs that we have made the right decision with our expansion to Europe and especially with our first location in Heidelberg. This is where start-up culture, entrepreneurial spirit and life science come together. This is where innovation is born," said Johannes Frühauf, founder and CEO of BioLabs. "It is our goal to accompany and support many young companies with their ideas from the life sciences with our network in the future. In this context, the event is an important building block in our work and sets positive impulses."
The Life Science Investors' Day will start at 9 a.m. on October 10 with a networking breakfast. This will be followed by pitches from life science startups in the fields of therapeutics, diagnostics, and deep-tech digital health. Afterwards, the participating investors will present themselves. In partnering sessions and at a joint lunch, founders and investors will have the opportunity to get to know each other better. "By bringing together founders and investors, we want to help close gaps in the value chain from technology transfer to the financing of clinical trials," says Thomas Prexl, Managing Director of Heidelberg Startup Partners. "In this way, we can identify and promote opportunities for good ideas at an early stage in order to develop them into marketable products."
"The Life Science Investors' Day is another important building block for supporting Gründer:innen here in the region. We are very pleased about the numerous registrations from both start-ups and investors," said Julia Schaft, managing director of BioRN. The Life Science Investors' Day 2022 will be the start of a series of events of this kind to enable a continuous exchange between investors and founders. It is planned to hold the Life Science Investors' Day annually.
Further information and registration options are available on the following website: https://www.life-science-investors-day.vc.
About the Heidelberg Startup Partner e. V.
The Heidelberg Startup Partner e. V. is an initiative of Heidelberg's leading research and educational institutions as well as the Rhine-Neckar Chamber of Industry and Commerce and the Heidelberg Technology Park. The aim of the initiative is to support startups with a technological and knowledge-based background. Based at the Heidelberg Technology Park, the interdisciplinary team of Heidelberg Startup Partners helps founders implement their business models and find financing opportunities. With regular events or specialized workshops, the Heidelberg Startup Partners aim to promote the startup scene and strengthen Heidelberg's attractiveness for startups in the fields of life sciences, artificial intelligence, virtual reality and IT.
Members of Heidelberg Startup Partner e.V. are the German Cancer Research Center (DKFZ),- EMBLEM, Heidelberg University of Education, SRH University of Applied Sciences, Heidelberg Technology Park, Science Value Heidelberg GmbH and Heidelberg University.
About the Life Science Accelerator Baden-Württemberg
The Life Science Accelerator Baden-Württemberg (http://www.lifescience-bw.de/) is a joint program of Technologiepark Heidelberg GmbH, Heidelberg Startup Partners e.V., the Department of Economic and Structural Development of the City of Mannheim, MAFINEX Gruenderverbund e.V. and the non-profit Foundation for Medical Innovations in Tübingen.
The program supports scientific and technological start-up teams in Baden-Württemberg focusing on biotechnology, medical technology and digital healthcare. The Life Science Accelerator Baden-Württemberg is funded by the Ministry of Economics, Labor and Housing Baden-Württemberg from the European Social Fund (ESF) and the state of Baden-Württemberg. Additional format: http://lifescience-bw.de/ . Start-up teams in the Accelerator participate in up to 24 workshops and gain access to experienced mentors and experts from the life sciences and healthcare sectors. Teams can also compete in front of investors and industry partners.
BioRN is the science and business cluster of the Rhine-Main-Neckar region around Heidelberg, one of the strongest biotech and life science hubs in Germany. As a non-profit network, BioRN unites more than 140 members in a unique ecosystem, including top universities, research institutions and technology parks. Ten global pharmaceutical companies have R&D sites or are active in the BioRN network. A large number of small and medium-sized companies, as well as local government organizations and advocacy groups, reinforce the cluster's excellence. With the vision "making life science matter...and innovation happen!", BioRN has developed a clear strategy to become the leading European life science cluster and attract global investment and talent. BioRN is also a founding partner of Biolabs Heidelberg, a leading shared lab space for life science and biotech startups that is part of the global BioLabs network. Follow BioRN on Twitter(@BioRNCluster) and LinkedIn. (www.biorn.org)
BioLabs defines itself as a catalyst for growth of new biotech companies, enabling the development of tomorrow's life science technologies. Young companies are provided with fully equipped and maintained laboratories at BioLabs, the size of which is scalable and grows with the needs of the young company. Likewise, exclusive access to key business services, they benefit from a powerful network of innovators and advisors, as well as site teams with unparalleled experience helping founders navigate the complex operational processes of building a biotech company. Start-ups often face very similar challenges and therefore benefit enormously from mutual exchange with each other. BioLabs teams are validated in their business ventures and become role models for other potential founders. BioLabs locations are in major innovation centers in North America and Europe in Paris and Heidelberg. Follow Twitter (@BioLabsHQ) and LinkedIn.